Five-year nationwide follow-up study of active surveillance for prostate cancer

European Urology

Volumn 67, Issue 2, 2015, Pages 233-238

  Loeb, Stacy ^a   Folkvaljon, Yasin ^b   Makarov, Danil V ^a   Bratt, Ola ^c   Bill Axelson, Anna ^d   Stattin, Pär ^e  

^a NEW YORK UNIVERSITY   (United States)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

Author keywords

Active surveillance; Adverse pathology; Predictors; Prostate cancer; Upgrading

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN;

ACTIVE SURVEILLANCE; ADULT; AGED; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CHARLSON COMORBIDITY INDEX; COMORBIDITY; EDUCATIONAL STATUS; FOLLOW UP; GLEASON SCORE; HUMAN; INTERMEDIATE RISK POPULATION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIDDLE AGED; PATIENT PREFERENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SWEDEN; BIOPSY; BLOOD; CANCER GRADING; DISEASE COURSE; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; REGISTER; RISK FACTOR; TIME FACTOR; WATCHFUL WAITING;

AGED; BIOPSY; DISEASE PROGRESSION; HUMANS; KALLIKREINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGISTRIES; RISK FACTORS; SWEDEN; TIME FACTORS; WATCHFUL WAITING;

EID: 84920731639     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.06.010     Document Type: Article

References (19)

1. P.A. Ganz, J.M. Barry, and W. Burke National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer Ann Int Med 156 2012 591 595
2. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 2010 1117 1123
3. S. Loeb, A. Berglund, and P. Stattin Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer J Urol 190 2013 1742 1749
4. National Prostate Cancer Register of Sweden. http://npcr.se/. Accessed May 28, 2014.
5. M.A. Dall'era, P.C. Albertsen, and C. Bangma Active surveillance for prostate cancer: a systematic review of the literature Eur Urol 62 2012 976 983
6. M. Van Hemelrijck, A. Wigertz, and F. Sandin Cohort profile: the National Prostate Cancer Register of Sweden and Prostate Cancer Data Base Sweden 2.0 Int J Epidemiol 42 2012 956 967
7. A. Berglund, H. Garmo, C. Tishelman, L. Holmberg, P. Stattin, and M. Lambe Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden J Urol 185 2011 833 839
8. The Melbourne Consensus Statement on Prostate Cancer Testing. BJU International Web site. http://www.bjuinternational.com/bjui-blog/the-melbourne-consensus-statement-on-prostate-cancer-testing/. Updated August 7, 2013. Accessed September 15, 2013.
9. S.M. Evans, J.L. Millar, and I.D. Davis Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011 Med J Austr 198 2013 540 545
10. R.A. Godtman, E. Holmberg, A. Khatami, J. Stranne, and J. Hugosson Outcome following active surveillance of men with screen-detected prostate cancer: results from the Göteborg Randomised Population-based Prostate Cancer Screening Trial Eur Urol 63 2013 101 107
11. G.P. McVey, S. McPhail, S. Fowler, G. McIntosh, D. Gillatt, and C.C. Parker Initial management of low-risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry BJU Int 106 2010 1161 1164
12. E.K. Lee, J. Baack, and H. Penn Active surveillance for prostate cancer in a veteran population Can J Urol 17 2010 5429 5435
13. J.J. Tosoian, B.J. Trock, and P. Landis Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185 2190
14. I.J. Dahabreh, M. Chung, and E.M. Balk Active surveillance in men with localized prostate cancer: a systematic review Ann Int Med 156 2012 582 590
15. L. Bellardita, T. Rancati, and M.F. Alvisi Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance Eur Urol 64 2013 30 36
16. E.S. Holmboe, and J. Concato Treatment decisions for localized prostate cancer: asking men what's important J Gen Int Med 15 2000 694 701
17. Y. Yan, G.F. Carvalhal, W.J. Catalona, and J.D. Young Primary treatment choices for men with clinically localized prostate carcinoma detected by screening Cancer 88 2000 1122 1130
18. D.M. Latini, S.L. Hart, and S.J. Knight The relationship between anxiety and time to treatment of patients with prostate cancer on surveillance J Urol 178 2007 826 831 discussion 831-2
19. A.C. Goh, M.A. Kowalkowski, D.E. Bailey Jr., M.W. Kazer, S.J. Knight, and D.M. Latini Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance BJU Int 110 2012 E50 E56